CKD-828 Primary Hypertension Trial(Dose-selection)

NCT01128322 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

430

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: S-Amlodipine, Telmisartan
DRUG: S-Amlodipine
DRUG: Telmisartan
DRUG: Placebo

Sponsor

Chong Kun Dang Pharmaceutical